Literature DB >> 16388373

Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b.

G A Marfia1, C Pachatz, C Terracciano, G Leone, S Bernardini, G Bernardi, R Massa.   

Abstract

Peripheral neuropathy associated with IgM monoclonal gammopathy of unknown significance is a common disorder, while the association of paraproteinaemic neuropathies with haematological malignancies is far less frequent. We report a 76-year-old patient with a subacute and rapidly progressive sensorimotor demyelinating polyneuropathy causing sensory ataxia, painful paraesthesias and marked motor and sensory deficit in four limbs. Monoclonal gammopathy of IgM type associated with a rectal low-grade B-cell non-Hodgkin lymphoma was detected. Research for anti-MAG and antiganglioside autoantibodies including anti-GM1 and anti-GQ1b evidenced a high titre of IgM antibodies against the disialosyl group of GD1b. This is the first report on a paraproteinaemic polyneuropathy with IgM autoantibodies against glycolipid GD1b associated with B-cell lymphoma. The IgM type of these autoantibodies suggests that they represent all or part of the paraprotein produced by lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388373     DOI: 10.1007/s10072-005-0500-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

Review 1.  Neurologic complications of non-Hodgkin's lymphoma.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

2.  Diffuse large B-cell lymphoma involving peripheral nervous system with IgM antibodies against GM1 and GD1b: A case report.

Authors:  Zhaocai Jiang; Weina Ju; Shen Luo; Yu Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Anti-myelin-associated glycoprotein peripheral neuropathy as the only presentation of low grade lymphoma: a case report.

Authors:  Costantine Albany
Journal:  Cases J       Date:  2009-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.